Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bobby Thomas

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Molecular Neurodegeneration|July 28, 2009
Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neuronsJoão Paulo L Daher, Mingyao Ying, Rebecca Banerjee, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 7, 2006
Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathyRainer von Coelln, Bobby Thomas, Shaida A Andrabi, et al.
Human Molecular Genetics|February 22, 2014
Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicityCliona Stack, Shari Jainuddin, Ceyhan Elipenahli, et al.
Plos One|June 2, 2009
Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcriptionLichuan Yang, Noel Y Calingasan, Bobby Thomas, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 18, 2009
Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)Eva Andres-Mateos, Rebeca Mejias, Masayuki Sasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2021
Bach1 derepression is neuroprotective in a mouse model of Parkinson's diseaseManuj Ahuja, Navneet Ammal Kaidery, Otis C Attucks, et al.
Biochimie|January 1, 2018
L-ascorbic acid: A true substrate for HIF prolyl hydroxylase?Andrey I Osipyants, Andrey A Poloznikov, Natalya A Smirnova, et al.
Antioxidants & Redox Signaling|July 4, 2012
Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's diseaseNavneet Ammal Kaidery, Rebecca Banerjee, Lichuan Yang, et al.
Human Molecular Genetics|November 10, 2005
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective functionCheng Wang, Han Seok Ko, Bobby Thomas, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 10, 2016
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like DiseaseManuj Ahuja, Navneet Ammal Kaidery, Lichuan Yang, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Molecular Neurodegeneration|July 28, 2009
Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neuronsJoão Paulo L Daher, Mingyao Ying, Rebecca Banerjee, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 7, 2006
Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathyRainer von Coelln, Bobby Thomas, Shaida A Andrabi, et al.
Human Molecular Genetics|February 22, 2014
Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicityCliona Stack, Shari Jainuddin, Ceyhan Elipenahli, et al.
Plos One|June 2, 2009
Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcriptionLichuan Yang, Noel Y Calingasan, Bobby Thomas, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 18, 2009
Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)Eva Andres-Mateos, Rebeca Mejias, Masayuki Sasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2021
Bach1 derepression is neuroprotective in a mouse model of Parkinson's diseaseManuj Ahuja, Navneet Ammal Kaidery, Otis C Attucks, et al.
Biochimie|January 1, 2018
L-ascorbic acid: A true substrate for HIF prolyl hydroxylase?Andrey I Osipyants, Andrey A Poloznikov, Natalya A Smirnova, et al.
Antioxidants & Redox Signaling|July 4, 2012
Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's diseaseNavneet Ammal Kaidery, Rebecca Banerjee, Lichuan Yang, et al.
Human Molecular Genetics|November 10, 2005
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective functionCheng Wang, Han Seok Ko, Bobby Thomas, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 10, 2016
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like DiseaseManuj Ahuja, Navneet Ammal Kaidery, Lichuan Yang, et al.
Pageof 7